Tap wealth of local products emerging to fight ‘neglected’ diseases of poor: study
(Program on Life Sciences, Ethics and Policy,McLaughlin-Rotman Centre for Global Health) World health experts have documented a wealth of innovative, affordable drugs, vaccines and diagnostic products created in China, India, Brazil and South Africa that are effective against “neglected” diseases of the poor. The McLaughlin Rotman Center for Global Health proposes a new global mechanism to help extend the benefits of such products into distant markets where they are urgently needed.
source : www.eurekalert.org
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Related News:
- Stanford Study: What Makes You Unique? Not Genes So Much As Surrounding Sequences
- Hutterite study: Vaccinating kids for flu may help prevent transmission, protect those who are not vaccinated
- Researchers Develop Tool To Help Study Prostate Cancer
- Hospice Study Finds Racial Disparities (CME/CE)
- Shoulder Function Not Fully Restored After Surgery: Henry Ford Hospital Study
- Hospice Study Finds Racial Disparities
- Phase III REGION-I Study Shows PEP005 (ingenol Mebutate) Gel 0.05% May Reduce Pre-Cancerous Skin Lesions In Patients With Actinic Keratosis
- Prolonged Use Of HRT Increases Incidence Of Lung Cancer By About 50 Percent: New Study
- pSivida Reports Presentation Of Additional Positive 24-Month Data From Iluvien(R) Phase 3 FAME™ Study For Diabetic Macular Edema At Angiogenesis
- Second Dose Of Gene Therapy For Inherited Blindness Proves Safe In Animal Study
Details :
Submited at Tuesday, November 3rd, 2009 at 7:00 am on Infectious Disease by admin
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















